AMYT.ESC1 CONTRA ADR AMRYT PHARM F+

Watchlist

0.000
0.0000.00%

Trading Dec 27 09:30 ET

0Market Cap0.00P/E (TTM)

CONTRA ADR AMRYT PHARM F+ Key Stats

According to the latest financial report of CONTRA ADR AMRYT PHARM F+, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Quarterly

FCF

Interested in knowing about CONTRA ADR AMRYT PHARM F+'s free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CONTRA ADR AMRYT PHARM F+ shows that the company's current ratio is --, indicating healthy liquidity.

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CONTRA ADR AMRYT PHARM F+, the quick ratio is --, indicating that the company can meet its short-term debt obligations.

Quarterly

ROE

Want to learn more about the financial health of CONTRA ADR AMRYT PHARM F+? The latest ROE figure is --, indicating that the company has stable profitability.

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CONTRA ADR AMRYT PHARM F+, the total asset return on investment (ROA) is --.

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check CONTRA ADR AMRYT PHARM F+'s latest financial report to see how their gross margin is doing - currently at --.

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CONTRA ADR AMRYT PHARM F+, the net profit margin is --, which is a good sign for its profitability.

Quarterly

Trending US Stocks